RESEARCH USE ONLY
This protocol template is a reference scaffold for laboratory, in-vitro, and animal-model research planning. It is not medical advice and is not intended for human administration. All ORYN peptides are sold strictly for research use.
NAD+ Pen Longevity Research Protocol
NAD+ (nicotinamide adenine dinucleotide) is one of the most-researched longevity coenzymes. Its role in mitochondrial function, sirtuin-pathway signalling, and DNA-repair pathways makes it a cornerstone of longevity research. This protocol template scaffolds an 8-week loading and maintenance research block using the ORYN NAD+ novadose pen format, optimised for cellular endpoint studies.
DURATION
8-week loading + maintenance block
FREQUENCY
Daily during loading, alternate-day during maintenance
PEPTIDES
NAD+ + NovaDose NAD+
CATEGORY
Longevity & mitochondrial research
Pens used in this protocol
Scientific background
NAD+ levels decline with age across multiple tissue types, and the longevity research literature has investigated multiple approaches to restoring or maintaining cellular NAD+. The direct NAD+ research protocol (as opposed to NAD+ precursor research like NR or NMN) delivers the coenzyme itself, which is the most direct exposure route. The pen format matters for this protocol because the dial-a-dose increments allow the loading/maintenance split to be implemented as dial changes rather than separate preparations — one pen, two phases, no reformulation.
RESEARCH FOCUS
Mitochondrial function, sirtuin-pathway activation, and cellular NAD+ levels in longevity research
Protocol overview
The standard longevity research block runs 8 weeks split into a 2-week loading phase (daily administration at higher dial) and a 6-week maintenance phase (alternate-day at lower dial). The loading phase establishes elevated cellular NAD+ levels quickly, and the maintenance phase holds those levels with less frequent administration. The 8-week window is long enough to observe downstream mitochondrial endpoints but short enough to remain a single research cycle.
Protocol phases
PHASE 1
Baseline week
DURATION
Days -7 to 0
DIAL SETTING
No administration
Baseline endpoint measurements. Cellular NAD+ levels, mitochondrial function markers, and any study-specific endpoints.
PHASE 2
Loading phase
DURATION
Weeks 1-2
DIAL SETTING
Higher dial setting, daily
Two weeks of daily administration at the higher dial setting to establish elevated cellular NAD+ levels. The daily schedule is the more aggressive phase of the protocol — this is where the pen's click-accuracy matters most, since any drift across 14 consecutive administrations would compound.
PHASE 3
Maintenance phase
DURATION
Weeks 3-8
DIAL SETTING
Lower dial setting, alternate-day
Six weeks of alternate-day administration at a lower dial setting. The 3× weekly schedule is sufficient to maintain the elevated NAD+ levels established in the loading phase. Dial change is a single setting adjustment — no new pen required.
PHASE 4
Washout
DURATION
Weeks 9-10
DIAL SETTING
No administration
Two-week washout before post-protocol endpoint measurements. Cellular NAD+ levels decline relatively quickly after cessation, so the washout window captures both peak post-protocol response and early return-to-baseline.
Key considerations
- •Research-use only. This protocol is for laboratory, in-vitro, and animal-model research planning — not human administration.
- •NAD+ is light-sensitive and thermally labile — keep the pen refrigerated and protected from direct light across the full research block.
- •The loading phase is the most administration-intensive part of the protocol. Schedule the loading phase when the researcher can be present daily.
- •Cellular NAD+ endpoints require specific assay methods — plan the endpoint-measurement workflow before starting the protocol.
- •Batch consistency is critical — NAD+ potency can drift across lots, so use the same pen batch across the full 8-week block.
Why the pen format for this protocol
- →Pre-mixed format is particularly important for NAD+ because the coenzyme is sensitive to reconstitution-variance — the pre-mixed pen removes that variable entirely.
- →Dial-a-dose loading-to-maintenance transition is a single setting change, no reformulation.
- →Refrigerated stability across the 8-week block means no freeze-thaw cycles that would degrade NAD+ potency.
- →Click-accuracy across the daily loading phase (14 consecutive administrations) means the exposure profile is clean enough for cellular-endpoint analysis.
- →Batch-locked CoA across the full block ensures endpoint data maps to a single potency specification.
Literature references
The NAD+ longevity research literature is extensive and still developing. Key research streams include mitochondrial function (Verdin et al.), sirtuin-pathway activation (Imai et al.), and age-related NAD+ decline (Gomes et al.). Most research protocols reference a specific cellular or systemic endpoint rather than general longevity, because 'longevity' as a standalone endpoint is difficult to measure in short research blocks.
STACKING OPTIONS
NAD+ is frequently combined with glutathione in longevity research protocols — glutathione handles oxidative-stress endpoints while NAD+ handles mitochondrial/sirtuin endpoints. Both ORYN products ship as independent pens, so the combined protocol runs both in parallel on the same timeline. See the NAD+ vs Glutathione comparison page for the research rationale.
Common research endpoints
◆
Cellular NAD+ levels — direct measurement in target tissues
◆
Mitochondrial function markers — membrane potential, respiration rates
◆
Sirtuin activity endpoints — SIRT1, SIRT3, SIRT6 activation markers
◆
DNA-repair pathway endpoints — PARP activity, repair kinetics
◆
Inflammatory markers — NAD+ has documented effects on inflammatory pathways
FAQ
Why loading + maintenance instead of a flat schedule?
The loading phase establishes elevated cellular NAD+ levels quickly, and the maintenance phase holds those levels with less frequent administration. A flat schedule would either take longer to establish the research exposure or would over-administer during the maintenance period.
Why is NAD+ light-sensitive?
NAD+ is a reduction-sensitive coenzyme, and light exposure can drive oxidation. The ORYN pen is designed to minimise light exposure during storage, and the pre-mixed format means the coenzyme is not exposed to room-temperature reconstitution cycles that would otherwise accelerate degradation.
Can I run NAD+ and glutathione on the same block?
Yes — this is a common longevity research stack. NAD+ handles mitochondrial/sirtuin endpoints while glutathione handles oxidative-stress endpoints. Both pens run in parallel on the same 8-week timeline.
Is the novadose pen different from the standard NAD+ pen?
The ORYN novadose pen is designed specifically for NAD+ and related longevity coenzymes — it has click-count increments optimised for NAD+ research dial ranges. Check the CoA for the exact specifications of the pen you're using.
What's the minimum measurable endpoint?
Cellular NAD+ levels are the most direct and most measurable endpoint for this protocol. Downstream endpoints (mitochondrial function, sirtuin activation) typically require specific assay workflows and longer research blocks to show robust effects.
Order the pens for this research protocol
Every ORYN peptide pen ships with a Certificate of Analysis, full batch documentation, and the pen-format mechanical accuracy that makes protocol replicability possible. Research use only.
OTHER RESEARCH PROTOCOLS
RECOVERY & TISSUE REPAIR
BPC-157 recovery
28-day research block · Daily administration, typically split across two time points
METABOLIC & INCRETIN RESEARCH
Tirzepatide metabolic
12-week research block · Weekly single administration
GH-AXIS RESEARCH STACK
GH-axis stack
12-week research block · Twice-daily split administration (morning and pre-sleep)
SKIN & COLLAGEN RESEARCH
GHK-Cu skin
6-week research block · Daily single administration